## Abstract Autoimmune diseases are characterized by the loss of tolerance toward selfβantigens and the induction of destructive immune responses leading to tissue damage. Most patients with autoimmune diseases are treated with immunosuppressive drugs that suppress the immune response in a nonβspec
Potential for phosphodiesterase inhibitors in the management of autoimmune diseases
β Scribed by Padmanabha Shenoy; Vikas Agarwal; Amita Agarwal; Ramnath Misra; Sita Naik
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 89 KB
- Volume
- 72
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a βFull Textβ option. The original article is trackable v
Substitution therapy with levodopa and a peripheral inhibitor of aromatic L-amino acid decarboxylase (AADC) is the cornerstone in the treatment of Parkinson's disease. Chronic therapy with levodopa, however, is associated with the occurrence of motor complications that are partially related to the p
## Abstract Plants protect themselves from arthropod herbivores both directly, by expressing biochemical and morphological traits that interfere with herbivore development or behavior, and indirectly, by facilitating the action of natural enemies of herbivores. These direct and indirect resistance
Around 1 in 4 patients with inflammatory bowel disease (IBD) present in childhood, the majority around the time of their pubertal growth spurt. This presents challenges over and above those of managing IBD in adults as this period is a time of dramatic psychological and physical transition for a chi